Patient-reported outcomes with insulin degludec/liraglutide (IDegLira) vs basal-bolus therapy in patients with type 2 diabetes: DUAL VII trial

Thumbnail Image
Identifiers
URI: http://hdl.handle.net/11268/7224

Publication date

2017

Authors

Doshi, Ankur
Gouet, D.
Oviedo, A.
Rodbard, H.W.

Advisors

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics

Google Scholar

Research Projects

Organizational Units

Journal Issue

Abstract

Description

UNESCO Subjects

Sistema endocrino
Tratamiento médico

Keywords

Bibliographic reference

Jódar Gimeno, E., Doshi, A., Gouet, D., Oviedo, A., Rodbard, H.W., Tentolouris, N., Busk, A.K., Basse, A., & Billings, L.K. (2017). Patient-reported outcomes with insulin degludec/liraglutide (IDegLira) vs basal-bolustherapy in patients with type 2 diabetes: DUAL VII trial. Trabajo presentado en la 53rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD).

Type of document

conference output

Collections

Otras Áreas de Investigación de Salud